The full findings of the study were presented during a late-breaking session at the 27th Congress of the International Society on Thrombosis and Haemostasis.
News
NICE Onpattro approval puts Alnylam back in hATTR running
NICE issued the drug a preliminary ‘no’, back in December 2018.
Darzalex, Ibrance among latest SMC decisions
The Scottish Medicines Consortium (SMC) has announced its latest round of decisions for NHS Scotland, publishing advice accepting three new medicines.
Options available for individual entry in the 2019 Communications Team of the Year competition
There are options available for individual entry in the 2019 PharmaTimes Communications Team of the Year competition, alongside the prestigious team challenges.
NHS England scraps 7 more drugs on prescription
NHS England has discarded certain items as they are of “low clinical effectiveness”.
Reversing sugar tax would be a ‘public health disaster’
The Royal College of Physicians of Edinburgh is calling for the sugar tax to be extended to other products such as caffeinated drinks, milkshakes and fruit smoothies.
Uni of Dundee, Eisai join forces for cancer drug discovery
The collaboration research agreement regards Proteolysis Targeting Chimeras, or PROTACs.
AZ to appeal NICE rejection for lung cancer drug
The committee didn’t OK the drug as the cost effectiveness estimates were above what NICE normally considers to be an acceptable use of NHS resources.
Malaria cases remain at highest level since 2011
In a bid to tackle the rise, anti-malarial drug Maloff Protect has been made available over-the-counter.
Xpovio combo bags FDA approval for refractory multiple myeloma
The application was also granted Fast Track designation, and Xpovio received Orphan Drug designation.
NICE OK for life-extending Vizimpro in lung cancer
It’s a change from the committee’s initial decision which found the tyrosine kinase inhibitor to not be a cost-effective use of NHS resources.
Oncimmune signs commercialisation partnership in Russia
The five-year initial term aims to generate revenues of at least £5 million.
Communiqué Awards 2019: Winners announced!
Who came out on top in the The Communiqué Awards 2019?
Oxford Health to use Oxehealth technology to transform night observations
The technology uses an optical sensor to detect movement, pulse and breathing rate and helps nurses conduct observations more quickly but no less safely.
Janssen hands back rights to Hanmi’s diabetes/obesity drug
The drug “fell short” of Janssen’s expectations on blood glucose control in obese patients
